Search Medical Condition
Please enter condition
Please choose location

Avda, Campanar 21, Spain Clinical Trials

A listing of Avda, Campanar 21, Spain clinical trials actively recruiting patients volunteers.

RESULTS

Found (126) clinical trials

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

Acute myeloid leukaemia (AML) is a form of cancer that is common in older patients. Mutations in the isocitrate dehydrogenase enzyme 2 (IDH2) have been found in approximately 15% of patients with AML. The outcome of first line chemotherapy treatment is poor and many patients fail to attain complete remission ...

Phase

0.0 miles

Learn More »

Phase

0.43 miles

Learn More »

Preoperative Olaparib Endometrial Carcinoma Study (POLEN)

The main objective of the present proposal study is to assess the biological consequences of PARP inhibition in type I primary EC, in patients who receive therapy with AZD2281 during the period of time between diagnosis and surgery. This is a phase 0 trial or "Exploratory Investigational New Drug" study, ...

Phase N/A

0.58 miles

Learn More »

Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues

The intention of this study is to investigate how many patients with prostate cancer, planned to be treated with LHRH analogues without history of surgery or radiotherapy, are suffering from LUTS. In addition the effect of LHRH analogues on the improvement of theses primary LUTS symptoms over time will be ...

Phase N/A

0.58 miles

Learn More »

Long Term Follow Up Protocol for NiCord Patients

This is an observational study that will monitor patient's clinical outcomes. A patient can enroll in the NiCord® Long Term Follow Up Protocol only after the informed consent has been signed, and he/she has completed the study specific follow-up.

Phase N/A

0.58 miles

Learn More »

AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.

This program initially aims to recruit 1300 breast cancer patients from a large number of hospitals across Europe. Eligible patients are those who are 18 or older, either female or male, and who have not received more than 1 type of treatment from the time metastases were discovered, metastasi(e)s has ...

Phase N/A

0.58 miles

Learn More »

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

The overall aim of the trial is to investigate the safety and anti-tumour activity of an experimental drug BI 836845 taken together with the prostate cancer drug, enzalutamide, compared to enzalutamide given alone, in castrate resistant prostate cancer (CRPC) patients that have previously been treated and failed on docetaxel and ...

Phase

0.58 miles

Learn More »

Safety and Efficacy Study of CC-486 and Durvalumab in Subjects With Myelodysplastic Syndromes

Evaluate the safety and efficacy of CC-486 and Durvalumab in Subjects with Myelodysplastic Syndromes who failed to achieve an objective response post iHMA treatment

Phase

0.58 miles

Learn More »

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or radiotherapy or both.

Phase

0.58 miles

Learn More »